Protalix BioTherapeutics (PBDA.F) Q2 2025 Earnings

May 9Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.04
0
0.05
0.09

Details

Expected EPS
0.0710824
Actual EPS
-0.04442650000000001
Surprise EPS
-0.12
Surprise Percent
-162.5%

Description

⁨Protalix BioTherapeutics⁩ (⁦PBDA.F⁩) has reported earnings of ⁦-0.04442650000000001⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts